Cephalexin monohydrate, USP grade, ≥95%
Cephalexin Monohydrate
Application Notes
Cephalexin is a cephalosporin antibiotic used to study the effect of expression, binding, and inhibition of PBP3 and other penicillin-binding proteins (PBPs) on bacterial cell wall mucopeptide synthesis. Cephalexin and other antibiotics have been shown to inhibit p-aminohippurate uptake by the rat renal organic anion transporter 1, as expressed in Xenopus laevis oocytes. A study of CHO cells transfected with the vector for the H+-coupled peptide transporter PEPT1 has shown that cephalexin is a competitor for dipeptide transport. Cephalexin has been used to culture E. coli at 10 µg/mL for the expression of fusion proteins.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Antibacterial | Antibiotics
SKU | 02150585-CF |
Alternate Names | 7-(d-a-Aminophenylacetamido)desacetoxycephalosporanic acid; Cefalexin monohydrate; [6R-[6α,7β(R*)]]-7-[(aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-carboxylic acid monohydrate; 7-(Dα-aminophenylacetamido) desacetoxycephalosporanic acid monohydrate |
Application Notes | Cephalexin is a cephalosporin antibiotic used to study the effect of expression, binding, and inhibition of PBP3 and other penicillin-binding proteins (PBPs) on bacterial cell wall mucopeptide synthesis. Cephalexin and other antibiotics have been shown to inhibit p-aminohippurate uptake by the rat renal organic anion transporter 1, as expressed in Xenopus laevis oocytes. A study of CHO cells transfected with the vector for the H+-coupled peptide transporter PEPT1 has shown that cephalexin is a competitor for dipeptide transport. Cephalexin has been used to culture E. coli at 10 µg/mL for the expression of fusion proteins. |
Base Catalog Number | 150585 |
Beilstein Registry Number | 965503 |
Biochemical Physiological Actions | Cephalexin disrupts the synthesis of the peptidoglycan layer of bacterial cell walls which is responsible for cell wall structural integrity. Peptidoglycan synthesis is facilitated by transpeptidases known as penicillin-binding proteins (PBPs). PBPs bind to the D-Ala-D-Ala at the end of muropeptides (peptidoglycan precursors) to crosslink the peptidoglycan. Cephalexin antibiotics mimic the D-Ala-D-Ala site, thereby competitively inhibiting PBP crosslinking of peptidoglycan. |
CAS # | 23325-78-2 |
EC Number | 239-773-6 |
Extinction Coefficient | 7.75(Lit.) |
Format | Powder |
Grade | USP |
Hazard Statements | H317-H334 |
Melting Point | 326.8 °C |
Molecular Formula | C16H17N3O4S·H2O |
Molecular Weight | 365.404 g/mol |
Optical Rotation | +149° to +158° (pH 4.4) |
Personal Protective Equipment | Dust mask , Eyeshields, Faceshields, Gloves |
pKa | 5.2, 7.3(Lit.) |
Potency | 950 - 1010 µg/mg (anhydrous basis) |
Purity | ≥95% |
RTECS Number | XI0350000 |
Safety Symbol | GHS08 |
Solubility | Water Solubility1.789 mg/mL as monohydrate salt (solubility in water is low at room temperature; 1 or 2 mg/mL may be dissolved readily, but higher concentrations are obtained with increasing difficulty) |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
UV Visible Absorbance | 260 - 262 nm (water) |